Specialized Compositions for Promoting FGF21 Secretion in Niche Environments
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts the original composition for promoting FGF21 secretion to specialized, high-stress environments, such as high-altitude, disaster relief, high-security, and extreme physical stress situations.
Background and Problem Solved
The original patent disclosed a composition for promoting FGF21 secretion, but it did not address the unique challenges of specific, high-stress environments. The present inventive concept solves this problem by developing tailored compositions that thrive in these niche environments, thereby ensuring the effective promotion of FGF21 secretion.
Detailed Description of the Inventive Concept
The inventive concept comprises specialized compositions featuring Bifidobacterium bacteria adapted to specific, high-stress environments. For example, in high-altitude environments, the composition includes a Bifidobacterium bacterium adapted to thrive in low-oxygen conditions. In disaster relief settings, the composition is formulated for ease of transportation and storage in emergency situations. Similarly, in high-security environments, the composition is contained in a secure, tamper-evident package.
Novelty and Inventive Step
The new claims introduce novel, non-obvious adaptations of the original composition to address the specific challenges of high-stress environments. These adaptations, such as the selection of Bifidobacterium bacteria for their ability to increase FGF21 secretion in cold-stressed subjects or their containment in secure packages, demonstrate a clear inventive step beyond the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include compositions tailored to other high-stress environments, such as extreme temperatures, high-radiation areas, or isolated communities. Variations of the composition could also include different strains of Bifidobacterium bacteria or additional components to enhance their efficacy.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in industries catering to high-stress environments, such as military, aerospace, disaster relief, and high-security organizations. The compositions could be marketed as specialized nutritional supplements or pharmaceutical products, offering a unique value proposition to customers operating in these niche environments.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Microbiology, probiotics, and metabolic health, with expertise in bacterial strain selection, physiological stress response, and metabolic modulation techniques
Person of Ordinary Skill (PHOSITA) Profile
A researcher or biotechnologist with advanced degree in microbiology, familiar with probiotic strain characterization, metabolic pathway interactions, and environmental adaptation of bacterial species
Obviousness Rationale
A person skilled in the art would recognize that adapting Bifidobacterium breve M-16V to specific environmental conditions represents a predictable extension of the original patent's core methodology of using bacterial strains to modulate physiological processes. The variations demonstrate standard engineering approaches to optimize bacterial performance across different stress environments. These adaptations follow established scientific principles of strain selection and targeted compositional modifications.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,579 |
|---|---|
| Title | Composition for promoting the secretion of FGF21 |
| Assignee(s) | Morinaga Milk Industry Co., Ltd. |